Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Embryo Ventures is a London-based venture capital firm founded in 2019, focusing on early-stage investments globally. The firm operates from its office at 35 Berkeley Square, Mayfair, London, and has established itself as a key player in the health and technology sectors. Embryo Ventures is dedicated to partnering with exceptional founders who are pioneering advancements in health and human experience.
With a portfolio that includes over 30 deals, Embryo Ventures emphasizes a thematic investment strategy that targets next-generation clinical technologies and consumer innovations. The firm does not operate as a traditional venture capital fund, which allows it to maintain agility in capital deployment without the constraints of LP commitments. This unique structure enables Embryo Ventures to act quickly and decisively in supporting its portfolio companies.
Embryo Ventures invests primarily in two sectors: Human Health and Human Experience. In the Human Health sector, the firm supports next-generation clinical and consumer technologies aimed at restoring, sustaining, and expanding human health. This includes innovations in surgical, procedural, and diagnostic technologies, as well as longitudinal technologies for chronic condition management and frontier innovations that enhance healthspan and cognitive performance.
In the Human Experience sector, Embryo Ventures focuses on technologies that redefine essential systems of daily life, such as connectivity, mobility, care, safety, and built environments. Their investment approach is thematic and opportunistic, allowing them to explore various models and categories across the globe. The firm typically invests in pre-seed to Series A stages, targeting companies that align with their mission to enhance human health and experiences.
Embryo Ventures has a diverse portfolio of 10 notable companies, each contributing to advancements in their respective fields:
This portfolio reflects Embryo Ventures' commitment to investing in companies that are at the forefront of health and human experience innovations.
To pitch Embryo Ventures, founders should send an email to hello@embryoventures.com. It is recommended to include a concise pitch deck that outlines the business model, market opportunity, and alignment with the firm's investment focus. While there are no specific application forms or portals mentioned, a well-structured email can facilitate a quicker response.
Response times may vary, but founders should expect a timely acknowledgment of their pitch. Warm introductions are beneficial but not strictly necessary.
What are Embryo Ventures' investment criteria?
Embryo Ventures focuses on early-stage investments in the Human Health and Human Experience sectors. They seek companies that are pioneering advancements in health technologies and redefining essential systems of daily life. The firm typically invests in pre-seed to Series A stages.
How can I pitch to Embryo Ventures?
Founders can reach out to Embryo Ventures via email at hello@embryoventures.com. It is advisable to include a clear overview of the business model, market opportunity, and how the startup aligns with their investment focus.
What makes Embryo Ventures different from traditional VC firms?
Embryo Ventures does not operate as a traditional venture capital fund, which allows for greater flexibility in capital deployment. This structure enables them to act quickly and support portfolio companies without the constraints of LP commitments.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, Embryo Ventures invests in early-stage companies, which typically range from pre-seed to Series A funding rounds.
What kind of support do portfolio companies receive?
Embryo Ventures adds value through strategic guidance, industry connections, and expertise in health and technology sectors. Their thematic investment approach allows them to identify and support innovative solutions that align with their mission.
What is the geographic focus of Embryo Ventures?
Embryo Ventures invests globally, with a primary focus on the UK and Europe, and a secondary focus on the US and other opportunistic markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.